# Arthritis & Rheumatology

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/arthritis-and-rheumatology/

## Facts

| Field | Value |
| --- | --- |
| APC (USD) | 4,940 |
| Citations | 209,218 |
| h-index | 187 |
| Homepage | https://onlinelibrary.wiley.com/journal/23265205 |
| Open Access | false |
| ISSN-L | 2326-5191 |
| ISSNs | 2326-5191,2326-5205 |
| OpenAlex ID | https://openalex.org/S4210186158 |
| Publisher | Wiley |
| Works | 5,505 |

## Journal papers

Showing 12 of 85.

- [2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis](https://scholariq.org/papers/2015-american-college-of-rheumatology-guideline-for-the-treatment-of-rheumatoid/)
- [2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus](https://scholariq.org/papers/2019-european-league-against-rheumatism-american-college-of-rheumatology/)
- [Contemporary Prevalence of Gout and Hyperuricemia in the United States and Decadal Trends: The National Health and Nutrition Examination Survey, 2007–2016](https://scholariq.org/papers/contemporary-prevalence-of-gout-and-hyperuricemia-in-the-united-states-and/)
- [International Consensus Guidance Statement on the Management and Treatment of IgG4‐Related Disease](https://scholariq.org/papers/international-consensus-guidance-statement-on-the-management-and-treatment-of/)
- [Anifrolumab, an Anti–Interferon‐α Receptor Monoclonal Antibody, in Moderate‐to‐Severe Systemic Lupus Erythematosus](https://scholariq.org/papers/anifrolumab-an-anti-interferon-receptor-monoclonal-antibody-in-moderate-to/)
- [2020 American College of Rheumatology Guideline for the Management of Gout](https://scholariq.org/papers/2020-american-college-of-rheumatology-guideline-for-the-management-of-gout/)
- [2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases](https://scholariq.org/papers/2020-american-college-of-rheumatology-guideline-for-the-management-of/)
- [2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative](https://scholariq.org/papers/2016-classification-criteria-for-macrophage-activation-syndrome-complicating/)
- [2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups](https://scholariq.org/papers/2017-european-league-against-rheumatism-american-college-of-rheumatology-2/)
- [The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4‐Related Disease](https://scholariq.org/papers/the-2019-american-college-of-rheumatology-european-league-against-rheumatism-2/)
- [IgG4‐Related Disease: Clinical and Laboratory Features in One Hundred Twenty‐Five Patients](https://scholariq.org/papers/igg4-related-disease-clinical-and-laboratory-features-in-one-hundred-twenty-five/)
- [Impact of Exercise Type and Dose on Pain and Disability in Knee Osteoarthritis: A Systematic Review and Meta‐Regression Analysis of Randomized Controlled Trials](https://scholariq.org/papers/impact-of-exercise-type-and-dose-on-pain-and-disability-in-knee-osteoarthritis-a/)

## Journal top topics

Showing 8 of 25.

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Autoimmune and Inflammatory Disorders Research](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders-research/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Osteoarthritis Treatment and Mechanisms](https://scholariq.org/topics/osteoarthritis-treatment-and-mechanisms/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Inflammatory Myopathies and Dermatomyositis](https://scholariq.org/topics/inflammatory-myopathies-and-dermatomyositis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.